Acute Effects of Oxygen Supplementation Among IPF Patients
NCT03688334
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG:
Oxygen 40 %
DRUG:
Medical air (sham O2)
Sponsor
George Papanicolaou Hospital